Surgical removal of the fallopian tubes as a permanent birth-control method can significantly lower the risk of common ovarian cancers [1].
This finding suggests a dual-purpose medical benefit for women seeking permanent sterilization. By addressing the primary site where most high-grade serous ovarian cancers originate, the procedure provides a preventive health advantage beyond simple contraception [1, 2].
The procedure, known as salpingectomy, involves the complete removal of the fallopian tubes [1, 3]. According to research published in JAMA Network Open on Feb. 2, 2026, this strategy can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80 percent [2].
Canadian investigators conducted the research, which was later reported by CBC News [1, 3]. The study highlights that because many of these cancers start in the tubes rather than the ovaries themselves, eliminating the tubes removes the primary environment where tumors develop [1, 2].
Despite these findings, the approach remains relatively little known among women in Canada [1]. Physicians and researchers said the procedure is recommended for those considering permanent birth-control options to maximize long-term health outcomes [1].
Medical professionals said that different forms of contraception carry different risk profiles. While surgical removal of the tubes provides this specific cancer-reduction benefit, other methods, such as birth-control pills containing estrogen and progestin, may increase the risk of certain other cancers [4].
“The procedure can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80 percent.”
This research shifts the clinical understanding of ovarian cancer by confirming that the fallopian tubes, not the ovaries, are often the starting point for the most aggressive tumors. For patients in Canada and elsewhere, this transforms a routine sterilization request into a critical cancer-prevention opportunity, potentially changing the standard of care for permanent contraception.
